Whole brain N-acetylaspartate concentration is conserved throughout normal aging
暂无分享,去创建一个
Achim Gass | Oded Gonen | Andreas U. Monsch | James S. Babb | Marc Sollberger | Lidia Glodzik | A. Monsch | A. Gass | J. Hirsch | J. Babb | O. Gonen | L. Glodzik | M. Amann | M. Sollberger | William E. Wu | L. Achtnichts | Michael Amann | Lutz Achtnichts | Jochen Hirsch | Lidia Glodzik
[1] Nick C Fox,et al. A longitudinal study of brain volume changes in normal aging using serial registered magnetic resonance imaging. , 2003, Archives of neurology.
[2] N. Schuff,et al. N-acetylaspartate as a marker of neuronal injury in neurodegenerative disease. , 2006, Advances in experimental medicine and biology.
[3] M Filippi,et al. Reproducibility of the whole-brain N-acetylaspartate level across institutions, MR scanners, and field strengths. , 2007, AJNR. American journal of neuroradiology.
[4] Henry Rusinek,et al. Fully automatic segmentation of the brain from T1‐weighted MRI using Bridge Burner algorithm , 2008, Journal of magnetic resonance imaging : JMRI.
[5] J. Morris,et al. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assesment of Alzheimer's disease , 1989, Neurology.
[6] R. Rudick,et al. Neurological disability correlates with spinal cord axonal loss and reduced N‐acetyl aspartate in chronic multiple sclerosis patients , 2000, Annals of neurology.
[7] Morris H. Baslow,et al. N-Acetylaspartate in the Vertebrate Brain: Metabolism and Function , 2003, Neurochemical Research.
[8] K. Krishnan,et al. Proton spectroscopy of human brain: Effects of age and sex , 1994, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[9] H. Larsson,et al. The concentration of N-acetyl aspartate, creatine + phosphocreatine, and choline in different parts of the brain in adulthood and senium. , 1993, Magnetic resonance imaging.
[10] A. Hofman,et al. Prevalence and risk factors of cerebral microbleeds , 2008, Neurology.
[11] Stephen M Smith,et al. Fast robust automated brain extraction , 2002, Human brain mapping.
[12] T R Brown,et al. A fast, reliable, automatic shimming procedure using 1H chemical-shift-imaging spectroscopy. , 1995, Journal of magnetic resonance. Series B.
[13] D J Jenden,et al. In vivo proton magnetic resonance spectroscopy of the normal aging human brain. , 1996, Life sciences.
[14] J. Frahm,et al. Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. , 1999, AJNR. American journal of neuroradiology.
[15] D. Bennett,et al. Alzheimer disease in the US population: prevalence estimates using the 2000 census. , 2003, Archives of neurology.
[16] J. Meyer,et al. White matter lesion in the elderly , 1992, Journal of the Neurological Sciences.
[17] R. Stern,et al. Rey-Osterrieth Complex Figure performance in adults with attention deficit hyperactivity disorder: a validation study of the Boston Qualitative Scoring System. , 1999, The Clinical neuropsychologist.
[18] Marianne Regard,et al. Children's Production on Verbal and Non-Verbal Fluency Tasks , 1982, Perceptual and motor skills.
[19] B. Pakkenberg,et al. Age-Induced White Matter Changes in the Human Brain: A Stereological Investigation , 1997, Neurobiology of Aging.
[20] J. Duyn,et al. Quantitative proton MR spectroscopic imaging of the human brain , 1996, Magnetic resonance in medicine.
[21] R. D'Agostino,et al. Prevalence and Correlates of Silent Cerebral Infarcts in the Framingham Offspring Study , 2008, Stroke.
[22] R I Grossman,et al. Total brain N‐acetylaspartate concentration in normal, age‐grouped females: Quantitation with non‐echo proton NMR spectroscopy , 1998, Magnetic resonance in medicine.
[23] Donna L. Hoyert,et al. Deaths: preliminary data for 2003 (USA) , 2005 .
[24] R. Mohs,et al. Consortium to establish a registry for Alzheimer's disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. , 2002, Psychopharmacology bulletin.
[25] M. J. Wade,et al. Neuron number in the entorhinal cortex and CA1 in preclinical Alzheimer disease. , 2001, Archives of neurology.
[26] A. Monsch,et al. Screening properties of the German IQCODE with a two-year time frame in MCI and early Alzheimer's disease , 2009, International Psychogeriatrics.
[27] Antonio Federico,et al. Diffuse axonal and tissue injury in patients with multiple sclerosis with low cerebral lesion load and no disability. , 2002, Archives of neurology.
[28] Saadallah Ramadan,et al. Neurospectroscopy: the past, present and future. , 2010, Chemical reviews.
[29] K. Takenouchi,et al. Metabolite changes with age measured by proton magnetic resonance spectroscopy in normal subjects , 1997 .
[30] E. Benarroch. N-Acetylaspartate and N-acetylaspartylglutamate , 2008, Neurology.
[31] E. Perret. The left frontal lobe of man and the suppression of habitual responses in verbal categorical behaviour. , 1974, Neuropsychologia.
[32] J R Griffiths,et al. Aging of the adult human brain: In vivo quantitation of metabolite content with proton magnetic resonance spectroscopy , 1999, Journal of magnetic resonance imaging : JMRI.
[33] A. Gass,et al. Whole-Brain N-Acetylaspartate MR Spectroscopic Quantification: Performance Comparison of Metabolite versus Lipid Nulling , 2008, American Journal of Neuroradiology.
[34] M. Rovaris,et al. Serial Whole-Brain N-Acetylaspartate Concentration in Healthy Young Adults , 2007, American Journal of Neuroradiology.
[35] Richard Hollister,et al. Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease , 1997, Annals of neurology.
[36] P. Scheltens,et al. A New Rating Scale for Age-Related White Matter Changes Applicable to MRI and CT , 2001, Stroke.
[37] M. Folstein,et al. The Mini-Mental State Examination. , 1983, Archives of general psychiatry.
[38] Giuseppe Scotti,et al. A whole brain MR spectroscopy study from patients with Alzheimer's disease and mild cognitive impairment , 2005, NeuroImage.
[39] R. Rudick,et al. Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.
[40] Oded Gonen,et al. Age dependence of regional proton metabolites T2 relaxation times in the human brain at 3 T , 2008, Magnetic resonance in medicine.
[41] K. Lim,et al. Estimating NAA in cortical gray matter with applications for measuring changes due to aging , 1997, Magnetic resonance in medicine.
[42] G. Fein,et al. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging , 1994, Annals of neurology.
[43] D. Hoyert,et al. Deaths: preliminary data for 2003. , 2005, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.
[44] B. Pakkenberg,et al. Marked loss of myelinated nerve fibers in the human brain with age , 2003, The Journal of comparative neurology.
[45] J. Moffett,et al. N-Acetylaspartate in the CNS: From neurodiagnostics to neurobiology , 2007, Progress in Neurobiology.
[46] C. Rorden,et al. Stereotaxic display of brain lesions. , 2000, Behavioural neurology.
[47] B. Reisberg,et al. What is vascular cognitive impairment , 2010 .
[48] L. Thurstone. Primary mental abilities. , 1938, Science.